Anadrol: Strength, Size, Reported Doses and Side Effects
Anadrol, at a glance
Anadrol is sought for fast size, fuller muscles and strength. The catch: a quick jump on the scale can include fluid, so it does not tell you how much muscle will remain.
Some people also report poor appetite or tiredness. Looking bigger and feeling stronger cannot reveal cholesterol, blood-pressure or liver problems.
Scale weight ↑ One number. Several contributors.
Lean-mass research can show change, but not all lean mass is muscle.
Retention can add size and weight without lasting muscle gain.
No fixed percentage applies. A scale or gym pump cannot tell these apart.
Reported dose, frequency and cycle length
50–150 mg
Reported daily total
One nonmedical advice example, taken orally.
Daily
Frequency
That example divides the total across the day.
Up to 6 weeks
Duration claim
The same advice proposes an equal-length break; neither establishes safety.
These amounts and the accompanying duration come from nonmedical advice: a reported example, not a studied regimen, proven safe range or prescription. Dividing doses or taking a break does not guarantee protection from liver injury.
Three results that are easy to confuse
| Compare | What it measures | What it cannot establish |
|---|---|---|
| Scale weight | Everything contributing to body mass | How much new contractile muscle was gained |
| Red-cell count | An effect on blood production | A safe endurance benefit |
| Lean mass | Non-fat tissue, including water | Guaranteed strength or lasting gains |
Does the weight gain translate into muscle?
The historical US label describes treatment of anemias caused by deficient red-cell production. That is a disease-specific use, not evidence that a healthy person benefits from a higher hematocrit. The label also warns about serious liver complications and edema. Historical Anadrol label
A separate 12-week study in 31 older men tested 50 or 100 mg daily and found increases in lean mass and strength, alongside adverse lipid and liver-marker changes. It does not predict results or safety in younger lifters.
A randomized trial in 89 people with HIV-associated wasting found weight and body-cell-mass improvements, alongside substantial liver-enzyme abnormalities. It studied a medically ill population under supervision. It does not tell a healthy lifter how much muscle a course will produce, or establish a safe performance dose. Original 2003 trial
Why swelling is not an estrogen diagnosis
Anadrol has a reputation for rapid fullness and water retention. Swelling, breast symptoms and blood-pressure changes should be assessed on their own merits; they do not prove a single estrogen mechanism. Adding an aromatase inhibitor based on appearance alone can introduce another drug without addressing the cause.
Record when symptoms began, all other compounds used and changes in body weight or blood pressure. That history is more useful than assuming every new symptom is “high E2.” See how ancillaries differ.
What matters more than the half-life
A short plasma half-life does not mean liver effects or red-cell changes stop by the next morning. A plotted peak describes the selected model; it is not a liver-injury forecast. Changing dose spacing may change the curve without resolving the reason a marker is abnormal.
Jaundice, dark urine or substantial abdominal pain need prompt medical assessment. Chest pain, severe breathlessness or a new one-sided swollen leg warrant urgent care. Bring the actual product packaging and medication list. Avoid treating blood donation or a “liver support” supplement as permission to continue through a problem.
Common questions
How is Anadrol different from Dianabol? Anadrol is oxymetholone; Dianabol is methandienone. They are different oral steroids, and neither their names nor a similar reputation for size and strength creates a dose equivalence. See the Dianabol guide.
Is Anadrol the same as Anavar? No. Anadrol is oxymetholone; Anavar is oxandrolone. Similar names do not imply equivalent amounts, effects or risk.
Does it always reduce appetite? No. The HIV-wasting trial reported improved appetite overall. Individual experiences in bodybuilding cannot replace that study result, and the result does not guarantee the same response in healthy users.
Can a four-week limit make it safe? The sources do not establish such a threshold. Duration is one part of exposure; product identity, other medicines and existing disease also matter.
Can a detection table tell me when testing is clear? No. Anti-doping tests may examine metabolites rather than the parent drug. Use the detection explanation to understand the distinction, not as a countdown.
Sources and review notes
Checked October 12, 2026. Reported-use advice and personal experiences are distinct from the clinical evidence below.
The FDA label is historical, not a claim of current local availability. The cited HIV-wasting study is the original AIDS publication (PMID 12646793); a separately published duplicate in HIV Clinical Trials was retracted as a redundant publication and is not used as evidence here. Clinical harms are also described in FDA adverse-event analysis.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.